These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29328445)
21. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer. Qu H; Xia Y; Li X Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960 [TBL] [Abstract][Full Text] [Related]
22. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy. Chen GX; Zheng LH; Liu SY; He XH World J Gastroenterol; 2011 Oct; 17(38):4289-97. PubMed ID: 22090785 [TBL] [Abstract][Full Text] [Related]
23. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
24. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969 [TBL] [Abstract][Full Text] [Related]
25. Regulation of apoptosis by Caspases under oxidative stress conditions in mice testicular cells: in vitro molecular mechanism. Kalia S; Bansal MP Mol Cell Biochem; 2009 Feb; 322(1-2):43-52. PubMed ID: 18979186 [TBL] [Abstract][Full Text] [Related]
26. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma. Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758 [TBL] [Abstract][Full Text] [Related]
27. [Adenovirus mediated IL-24 gene expression suppresses gastric cancer cell growth in vitro]. Bao W; Miao J; Sheng W; Shan Y; Li Z; Wang X; Jing Y; Han Y; Yang J Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1586-92. PubMed ID: 20112706 [TBL] [Abstract][Full Text] [Related]
28. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. Deininger MH; Grote E; Wickboldt J; Meyermann R J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075 [TBL] [Abstract][Full Text] [Related]
29. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells. Radziejewska I; Supruniuk K; Bielawska A Eur J Pharmacol; 2021 Jul; 902():174119. PubMed ID: 33930385 [TBL] [Abstract][Full Text] [Related]
30. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Yang Y; Xu W; Peng D; Wang H; Zhang X; Wang H; Xiao F; Zhu Y; Ji Y; Gulukota K; Helseth DL; Mangold KA; Sullivan M; Kaul K; Wang E; Prabhakar BS; Li J; Wu X; Wang L; Seth P Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191 [TBL] [Abstract][Full Text] [Related]
31. Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma. De la Rosa ÁJ; Rodríguez-Hernández Á; González R; Romero-Brufau S; Navarro-Villarán E; Barrera-Pulido L; Pereira S; Marín LM; López-Bernal F; Álamo JM; Gómez-Bravo MA; Padillo FJ; Muntané J Gene Ther; 2016 Jan; 23(1):67-77. PubMed ID: 26204498 [TBL] [Abstract][Full Text] [Related]
32. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation. Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846 [No Abstract] [Full Text] [Related]
34. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571 [TBL] [Abstract][Full Text] [Related]
35. The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. O'Malley BW; Sewell DA; Li D; Kosai K; Chen SH; Woo SL; Duan L Mol Endocrinol; 1997 Jun; 11(6):667-73. PubMed ID: 9171230 [TBL] [Abstract][Full Text] [Related]
36. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme. Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134 [TBL] [Abstract][Full Text] [Related]
37. An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53. Blaszczyk-Thurin M; Ertl IO; Ertl HC Scand J Immunol; 2002 Oct; 56(4):361-75. PubMed ID: 12234257 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions. Khattar M; Miyahara Y; Schroder PM; Xie A; Chen W; Stepkowski SM PLoS One; 2014; 9(1):e85882. PubMed ID: 24416451 [TBL] [Abstract][Full Text] [Related]